News | Brachytherapy Systems | March 18, 2016

Global Brachytherapy Market Reaches $705 Million in 2015

MEDraysintell projects 8 percent annual growth through 2030 to a total value of $2 billion

global brachytherapy market value, MEDraysintell

March 18, 2016 — The global market for brachytherapy reached $705 million in 2015, according to a report from MEDraysintell. Of that total, the high-dose rate (HDR) and low-dose-rate (LDR) segments accounted for just over 60 percent, while the microspheres and electronic brachytherapy commanded the remaining 40 percent.

The global brachytherapy market in 2015, expressed in U.S. dollars, has been affected by exchange rate fluctuations of the major currencies against the U.S. dollar. The brachytherapy market size displayed an annual growth of 3 percent during the last two years to reach $705 million in 2015. Without this exchange rate influence, MEDraysintell estimates that the brachytherapy market would have reached about $800 million, thereby exhibiting an annual growth of more than 8 percent.

The brachytherapy market is expected to reach $2 billion in 2030, growing by 8 percent annually, mainly driven by the microspheres market as well as electronic brachytherapy, which is gaining significant interest worldwide as a user-friendly technology. The LDR brachytherapy seeds market is expected to grow substantially in new large markets such as China and India because of its reduced cost, together with a high therapeutic success rate.

The top ten companies control about 80 percent of the world brachytherapy market and more than 20 companies share the remaining 20 percent. Several new companies have penetrated the brachytherapy market in the last few years and a few others are expected to join the market in the coming years.

For more information: www.medraysintell.com

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation